Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor.
Cancer Discov. 2022 Jun 2;12(6):1482-1499. doi: 10.1158/2159-8290.CD-21-1156.
Cancer Discov. 2022.
PMID: 35254416
Free PMC article.
Clinical Trial.